Status:
COMPLETED
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
Lead Sponsor:
Terumo Medical Corporation
Conditions:
Uterine Fibroid
Arteriovenous Malformations
Eligibility:
All Genders
18+ years
Brief Summary
This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.
Eligibility Criteria
Inclusion
- Subject is ≥ 18 years old
- Subject is scheduled for a procedure for treatment with HydroPearl microspheres using radial access.
- Subject is willing and able to complete follow-up requirements
- Subject is willing and able to sign a written Informed Consent form prior to participating in the registry.
Exclusion
- Unable to have a procedure with radial access for any reason.
- Participating in another clinical study which, in the opinion of the investigator, could impact the results of this registry.
- Pregnant or planning to become pregnant during the study.
Key Trial Info
Start Date :
February 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 11 2023
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT04272216
Start Date
February 6 2020
End Date
March 11 2023
Last Update
September 9 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California - Los Angeles
Los Angeles, California, United States, 90095
2
Rush University Medical Center
Chicago, Illinois, United States, 60612
3
SLU Department of Radiology
St Louis, Missouri, United States, 63110
4
Mount Sinai
New York, New York, United States, 11766